ADVANCES IN CARDIO-VASCULAR DISEASES

The Journal of Clinical & Experimental Cardiology is a scholarly Open Access journal which provides comprehensive coverage of modern practices in cardiovascular therapy designed for cardiovascular disease specialists and internists with a subspecialty in cardiology throughout the world. The journal features report on systemic hypertension, methodology, drugs, pacing, arrhythmia, preventive cardiology, congestive heart failure, valvular heart disease, congenital heart disease, and cardiomyopathy.

The journal serves the interest of both practicing clinicians and researchers. Both basic research and clinical papers can be submitted. In addition to original papers, we are launching a range of new manuscript types, including research articles, review articles, case reports, short communications and commentaries on relevant topics. Case reports are also acceptable. Controversial techniques, issues on health policy and social medicine are discussed and serve as useful tools for encouraging debate.

A minimally invasive treatment termed Percutaneous Transluminal Coronary Angioplasty (PTCA), also known as Percutaneous Coronary Intervention (PCI), serves to unblock stenosed or blocked coronary arteries, allowing free flow of blood to the myocardium. The lipid-rich plaque in the arteries causes the obstructions, which reduce blood flow to the heart. Atherosclerosis refers to the build-up of lipid-rich plaque in the arteries. Coronary Artery Disease (CAD) is the condition that occurs when atherosclerosis affects the coronary arteries. Patients with CAD typically present with dyspnea or exertional chest discomfort. Plaque rupture with platelet aggregation, abrupt thrombus development, and acute myocardial infarction all contribute to the sudden blockage of the coronary artery. These individuals exhibit diaphoresis, acute chest heaviness, and nausea.

Whenever the heart has indeed been exposed to a lot of stress and has become affected from not getting enough oxygen, cardiac biomarkers become visible in your blood. This could be the result of a heart attack. These levels, however, may be excessive for other circumstances. The concentrations of biomarkers are frequently used to determine the magnitude of a heart attack and the severity of your heart's damage immediately.

Regards

Calvin Parker

Managing Editor

J Clin Exp Cardiolog